Depression in Parkinson's disease: biogenic amines in CSF of ?de novo? patients
Authors:
- 1 December 1996
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 103 (12) , 1441-1445
Abstract
Introduction. Etiology of depression in Parkinsons disease (PD) is associated with serotonergic dysfunction. Previous studies, supporting this hypothesis, were performed on patients treated with antiparkinsonian drugs. To eliminate the influence of parkinsonian drug therapy and to elucidate significance of different biochemical pathways in PD associated with depression we determined levels of biogenic amines in cerebrospinal fluid (CSF) of 26 untreated “de novo” Parkinsonian patients.Material and methods. Patients were scored with the Hamilton depression scale (HD) and subdivided into groups with HD score ≥ 18 and HD score Results. In both groups no significant differences appeared between CSF levels of dopamine, noradrenaline, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxy-4-hydroxyphenylglycol and 5-hydroxyindole acetic acid, determined by high-performance liquid chromatography.Discussion. In contrast to previous studies on treated Parkinsonian patients no sign of altered serotonin metabolism especially in context with severity of depression in early stages of PD was found. Due to our results, we suggest, that biochemical markers of depression in CSF of PD may be influenced by antiparkinsonian therapy and that depression in PD may respond to serotonin reuptake inhibitors mainly in later stages of PD.Keywords
This publication has 14 references indexed in Scilit:
- Depression beim Parkinson-SyndromFortschritte der Neurologie · Psychiatrie, 1994
- Serotonergic dysfunction in depression associated with Parkinson's diseaseNeurology, 1992
- Biochemistry of Parkinson's disease 28 years later: A critical reviewMovement Disorders, 1989
- Depression and disability in Parkinson's disease: a follow-up of 132 casesPsychological Medicine, 1988
- The relationship of serotonin to depression in Parkinson's diseaseMovement Disorders, 1988
- Altered serotonin metabolism in depressed patients with Parkinson's diseaseNeurology, 1984
- Simultaneous Determination of 3,4‐Dihydroxyphenylalanine, 5‐Hydroxytryptophan, Dopamine, 4‐Hydroxy‐3‐Methoxyphenylalanine, Norepinephrine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, Serotonin, and 5‐Hydroxyindoleacetic Acid in Rat Cerebrospinal Fluid and Brain by High‐Performance Liquid Chromatography with Electrochemical DetectionJournal of Neurochemistry, 1982
- Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylaseJournal of Pharmacy and Pharmacology, 1968
- ParkinsonismNeurology, 1967
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960